Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150011/S034

Perceval Sutureless Heart Valve

Corcym S.r.l. · Decision date Oct 28, 2025

FDA DECISIONP150011/S034

What did the FDA decide?

FDA records P150011/S034 as a supplement to PMA P150011, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 28, 2025.

FDA approval order statement

removing an additional rejection criterion in the dimensional inspection
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 28, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150011/S034
Regulatory pathway
PMA supplement
Applicant
Corcym S.r.l.
Product code
LWR
Decision code
OK30
Decision date
Oct 28, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: heart-valve, non-allograft tissue.

Applicant
Corcym S.r.l.
Product code
LWR
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P150011/S034 received

    Application receipt date recorded by FDA.

  2. P150011/S033 · Related supplement

    PERCEVAL SUTURELESS HEART VALVE

  3. P150011/S034 · FDA decision

    30-Day Notice

  4. P150011/S035 · Related supplement

    Perceval Sutureless Heart Valve

Timeline entries are records held by MedtechLedger for P150011. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150011

Product / regulatory recordCompanyPathwayDecision dateSource
Corcym S.r.l.PMA supplementOct 28, 2025FDA
Corcym S.r.l.PMA supplementDec 22, 2025FDA

Explore the linked device profile

Other records with product code LWR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Corcym S.r.l.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Via Crescentino Sn, Saluggia, 13040

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records